Market Tracker

09/18 6:05pm ET

Trovagene Inc (NASDAQ:TROV)

5.29
Data as of 3:59pm ET
 -0.14 / -2.58%
Today’s Change
2.97
Today|||52-Week Range
8.50
-7.84%
Year-to-Date

Today’s Trading

Previous close5.43
Today’s open5.41
Day’s range5.22 - 5.47
Volume76,879
Average volume (3 months)155,372
Market cap$102.6M
Dividend yield--
Data as of 3:59pm ET, 09/18/2014

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-11.43%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book5.03

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.06-0.70%
GALTGalectin Therapeutic...-0.16-2.79%
QTNTQuotient Ltd+0.67+7.26%
GBIMGlobeImmune Inc-0.21-2.27%
Data as of 4:14pm ET, 09/18/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts